Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid-β peptide

被引:78
作者
Sponne, I
Fifre, A
Kriem, B
Koziel, V
Bihain, B
Oster, T
Olivier, JL
Pillot, T
机构
[1] Univ Nancy 1, INSERM, EMI 0014, F-54505 Vandoeuvre Les Nancy, France
[2] Lab Med & Therapeut Mol, F-54505 Vandoeuvre Les Nancy, France
[3] Univ Metz, EA3472, LIMBP, F-57000 Metz, France
关键词
Alzheimer's disease; membrane fluidity; oxidative stress; cytoskeleton;
D O I
10.1096/fj.03-0372fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuronal cell death in Alzheimer's disease (AD) is partly induced by the interaction of the amyloid-P peptide (Abeta) with the plasma membrane of target cells. Accordingly, recent studies have suggested that cholesterol, an important component of membranes that controls their physical properties and functions, plays a critical role in neurodegenerative diseases. We report here that the enrichment of the neuronal plasma membrane with cholesterol protects cortical neurons from apoptosis induced by soluble oligomers of the Abeta(1-40) peptide. Conversely, cholesterol depletion using cyclodextrin renders cells more vulnerable to the cytotoxic effects of the Abeta-soluble oligomers. Increasing the cholesterol content of small unilamellar liposomes also decreases Abeta-dependent liposome fusion. We clearly demonstrate that cholesterol protection is specific to the soluble conformation of Abeta, because we observed no protective effects on cortical neurons treated by amyloid fibrils of the Abeta(1-40) peptide. This may provide a new opportunity for the development of an effective AD therapy as well as elucidate the impact of the cholesterol level during AD development.
引用
收藏
页码:836 / +
页数:24
相关论文
共 58 条
[1]   DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay [J].
Anderson, AJ ;
Su, JH ;
Cotman, CW .
JOURNAL OF NEUROSCIENCE, 1996, 16 (05) :1710-1719
[2]   Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides [J].
Arispe, N ;
Doh, M .
FASEB JOURNAL, 2002, 16 (12) :1526-1536
[3]  
BI X, 2001, SOC NEUR ABSTR, V27
[4]  
Bodovitz S, 1996, J BIOL CHEM, V271, P4436
[5]   Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation [J].
Chui, DH ;
Tanahashi, H ;
Ozawa, K ;
Ikeda, S ;
Checler, F ;
Ueda, O ;
Suzuki, H ;
Araki, W ;
Inoue, H ;
Shirotani, K ;
Takahashi, K ;
Gallyas, F ;
Tabira, T .
NATURE MEDICINE, 1999, 5 (05) :560-564
[6]   Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-β peptide with membrane lipid [J].
Curtain, CC ;
Ali, FE ;
Smith, DG ;
Bush, AI ;
Masters, CL ;
Barnham, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :2977-2982
[7]  
DEA D, 2001, SOC NEUR ABSTR, V27
[8]   Molecular basis of Alzheimer's disease [J].
Drouet, B ;
Pinçon-Raymond, M ;
Chambaz, J ;
Pillot, T .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (05) :705-715
[9]   ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-β peptide [J].
Drouet, B ;
Fifre, A ;
Pinçon-Raymond, M ;
Vandekerckhove, J ;
Rosseneu, M ;
Guéant, JL ;
Chambaz, J ;
Pillot, T .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :117-127
[10]   Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus:: Specific changes in Alzheimer's disease [J].
Eckert, GP ;
Cairns, NJ ;
Maras, A ;
Gattaz, WF ;
Müller, WE .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (04) :181-186